These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37600707)

  • 1. Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma.
    Ye Y; Luo Y; Guo T; Zhang C; Sun Y; Xu A; Ji L; Ou J; Wu SY
    Front Endocrinol (Lausanne); 2023; 14():1179050. PubMed ID: 37600707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer.
    Luo Y; Ye Y; Chen Y; Zhang C; Sun Y; Wang C; Ou J
    Front Immunol; 2023; 14():1140993. PubMed ID: 36993976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic prediction and multidimensional dissections of a macrophages M0-related gene signature in liver cancer.
    Xu X; Wang J
    Front Endocrinol (Lausanne); 2023; 14():1153562. PubMed ID: 37033261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity.
    Zhang Y; Ye Y; Xu A; Luo Y; Sun Y; Zhang W; Ji L
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11979-11994. PubMed ID: 37422541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer.
    Yu Z; Zhu Y; Ji J
    Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Four-Cell-Senescence-Regulator-Gene Prognostic Index Verified by Genome-Wide CRISPR Can Depict the Tumor Microenvironment and Guide Clinical Treatment of Bladder Cancer.
    Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhong XY; Zeng N; Ma SY; He HD; Zhang ZB; Wang SG; Xia QD
    Front Immunol; 2022; 13():908068. PubMed ID: 35898492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel anoikis-related gene signature predicts prognosis in patients with breast cancer and reveals immune infiltration.
    Tang C; Qin L; Li J
    Medicine (Baltimore); 2023 Oct; 102(43):e35732. PubMed ID: 37904416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer.
    Zhang H; Yu X; Yang J; He G; Zhang X; Wu X; Shen L; Zhou Y; Cheng X; Liu X; Zhu Y
    Front Immunol; 2022; 13():933779. PubMed ID: 36090993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer.
    Li C; Zhang Y
    BMC Med Genomics; 2023 Jul; 16(1):158. PubMed ID: 37422644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
    Tang W; Xu F; Zhao M; Zhang S
    BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.
    Shen J; Zhang W; Jin Q; Gong F; Zhang H; Xu H; Li J; Yao H; Jiang X; Yang Y; Hong L; Mei J; Song Y; Zhou S
    Oncol Res; 2023; 32(2):339-351. PubMed ID: 38186570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer.
    Ren X; Cui H; Dai L; Chang L; Liu D; Yan W; Zhao X; Kang H; Ma X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):119. PubMed ID: 38466449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment.
    Zhou N; Kong D; Lin Q; Yang X; Zhou D; Lou L; Huang F
    Cancer Genet; 2023 Aug; 276-277():17-29. PubMed ID: 37343507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y; Liu H; Fu H; Ding GS; Teng F
    Front Immunol; 2022; 13():974377. PubMed ID: 36458010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
    Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
    Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-Related Genes to Construct a Novel Prognostic Model of Breast Cancer: A Chemosensitivity-Based Study.
    Deng ZM; Hu W; Dai FF; Yuan MQ; Hu M; Cheng YX
    Front Immunol; 2021; 12():734745. PubMed ID: 34764953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Senescence-Related Signature Predicts Prognosis and Characterization of Tumor Microenvironment Infiltration in Pancreatic Cancer.
    Hua H; Zheng C; Fan J; Li X; Xie W; Chen J; Yu C
    Biomed Res Int; 2022; 2022():1916787. PubMed ID: 36518628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.